Our focus is speed and efficiency. Our discovery platform uses microfluidics to screen millions of single immune cells per day for antibodies with specific properties and functions. This requires seamless integration from antibody selection through to validation. We design complex screening assays and develop cell lines, cultures, media, and reagents for species-specific applications. Using engineering, robotics, and machine vision to streamline our screening process, we continuously push our throughput in search of the best antibodies from natural immune responses.